Hulio Kit
Product Images NDC 83257-019

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Hulio (NDC 83257-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Biologics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Study Ra-iii Acr 20 Responses Over 52 Weeks (Image 01)

Figure 1. Study Ra-iii Acr 20 Responses Over 52 Weeks (Image 01)
FDA Label Image

Figure 2. Asas 20 Response By Visit, Study As-i (Image 02)

Figure 2. Asas 20 Response By Visit, Study As-i (Image 02)
FDA Label Image

Hulio Pen Logo (Image 03)

Hulio Pen Logo (Image 03)
FDA Label Image

Pen Instructions For Use Figure A (Image 04)

Pen Instructions For Use Figure A (Image 04)
FDA Label Image

Pen Instructions For Use Figure B (Image 05)

Pen Instructions For Use Figure B (Image 05)
FDA Label Image

Pen Instructions For Use Figure C (Image 06)

Pen Instructions For Use Figure C (Image 06)
FDA Label Image

Pen Instructions For Use Figure D (Image 07)

Pen Instructions For Use Figure D (Image 07)
FDA Label Image

Pen Instructions For Use Figure E (Image 08)

Pen Instructions For Use Figure E (Image 08)
FDA Label Image

Pen Instructions For Use Figure F (Image 09)

Pen Instructions For Use Figure F (Image 09)
FDA Label Image

Pen Instructions For Use Figure G (Image 10)

Pen Instructions For Use Figure G (Image 10)
FDA Label Image

Pen Instructions For Use Figure H (Image 11)

Pen Instructions For Use Figure H (Image 11)
FDA Label Image

Pen Instructions For Use Figure I (Image 12)

Pen Instructions For Use Figure I (Image 12)
FDA Label Image

Pen Instructions For Use Figure J (Image 13)

Pen Instructions For Use Figure J (Image 13)
FDA Label Image

Hulio Syringe Logo (Image 14)

Hulio Syringe Logo (Image 14)
FDA Label Image

Instructions For Use Figure A (Image 15)

Instructions For Use Figure A (Image 15)
FDA Label Image

Instructions For Use Figure B (Image 16)

Instructions For Use Figure B (Image 16)
FDA Label Image

Instructions For Use Figure C (Image 17)

Instructions For Use Figure C (Image 17)
FDA Label Image

Instructions For Use Figure D (Image 18)

Instructions For Use Figure D (Image 18)
FDA Label Image

Instructions For Use Figure E (Image 19)

Instructions For Use Figure E (Image 19)
FDA Label Image

Instructions For Use Figure F (Image 20)

Instructions For Use Figure F (Image 20)
FDA Label Image

Instructions For Use Figure G (Image 21)

Instructions For Use Figure G (Image 21)
FDA Label Image

Instructions For Use Figure H (Image 22)

Instructions For Use Figure H (Image 22)
FDA Label Image

Instructions For Use Figure I (Image 23)

Instructions For Use Figure I (Image 23)
FDA Label Image

Hulio Prefilled Syringe Carton (20 mg/0.4 mL)

Hulio Prefilled Syringe Carton (20 mg/0.4 mL)
FDA Label Image

Hulio Prefilled Syringe Carton (40 mg/0.8 mL)

Hulio Prefilled Syringe Carton (40 mg/0.8 mL)
FDA Label Image

Hulio Prefilled Pen (40 mg/0.8 mL)

Hulio Prefilled Pen (40 mg/0.8 mL)
FDA Label Image

Figure 3: Kaplan-meier Curves Summarizing Time To Treatment Failure On Or After Week 6 (study Uv I) Or Week 2 (study Uv Ii) (Image 27)

Figure 3: Kaplan-meier Curves Summarizing Time To Treatment Failure On Or After Week 6 (study Uv I) Or Week 2 (study Uv Ii) (Image 27)